Nanthip Prathumsap
Chiang Mai, 50200, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.
Journal: bioRxiv : the preprint server for biology
Published: September 18, 2025
Targeting mitochondrial dynamics emerges as an effective strategy of cardioprotection against trastuzumab-induced mitochondrial functional aberrations and cardiotoxicity in rats.
Journal: European journal of pharmacology
Published: November 28, 2024
Corrigendum to "Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis" [Pharmacol. Res. 173 (2021) 105882].
Journal: Pharmacological research
Published: April 02, 2024
Muscarinic and nicotinic receptors stimulation by vagus nerve stimulation ameliorates trastuzumab-induced cardiotoxicity via reducing programmed cell death in rats.
Journal: Toxicology and applied pharmacology
Published: March 24, 2024
Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways.
Journal: Molecular neurobiology
Published: August 01, 2023
Potential roles of 4HNE-adducted protein in serum extracellular vesicles as an early indicator of oxidative response against doxorubicin-induced cardiomyopathy in rats.
Journal: Current research in toxicology
Published: June 28, 2023
Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction.
Journal: Biochemical pharmacology
Published: June 04, 2023
Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats.
Journal: Life sciences
Published: May 31, 2023
Corrigendum to "Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics" [Biochem. Pharmacol. 192 (2021) 114743].
Journal: Biochemical pharmacology
Published: January 21, 2023
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways.
Journal: Molecular medicine (Cambridge, Mass.)
Published: October 21, 2022
Last Updated: 09/26/2026